X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (680) 680
Patent (102) 102
Publication (74) 74
Book / eBook (33) 33
Paper (16) 16
Book Chapter (13) 13
Conference Proceeding (12) 12
Newspaper Article (12) 12
Book Review (11) 11
Dissertation (10) 10
Reference (3) 3
Magazine Article (2) 2
Data Set (1) 1
Report (1) 1
Streaming Audio (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (210) 210
index medicus (194) 194
male (186) 186
female (167) 167
middle aged (119) 119
adult (114) 114
aged (95) 95
animals (90) 90
aged, 80 and over (60) 60
physics (56) 56
human necessities (52) 52
neurosciences (48) 48
hygiene (47) 47
medical or veterinary science (47) 47
analysis (45) 45
clinical neurology (43) 43
performing operations (43) 43
transporting (43) 43
treatment outcome (43) 43
chemistry (34) 34
electricity (34) 34
rats (34) 34
prospective studies (30) 30
care and treatment (29) 29
research (29) 29
adolescent (28) 28
depression (28) 28
metallurgy (27) 27
microbiology (27) 27
surgery (27) 27
oncology (26) 26
young adult (26) 26
devices for introducing media into, or onto, the body (25) 25
devices for producing or ending sleep or stupor (25) 25
devices for transducing body media or for taking media fromthe body (25) 25
abridged index medicus (24) 24
pharmacology & pharmacy (24) 24
high energy physics - experiment (23) 23
orthopedics (23) 23
electric communication technique (22) 22
time factors (22) 22
biochemistry & molecular biology (21) 21
rehabilitation (21) 21
article (20) 20
mice (20) 20
organic chemistry (20) 20
physics - high energy physics - experiment (20) 20
separation (20) 20
experiment (19) 19
high energy physics (19) 19
peptides (19) 19
retrospective studies (19) 19
risk factors (19) 19
anesthesiology (18) 18
follow-up studies (18) 18
hematology (18) 18
physical or chemical processes or apparatus in general (18) 18
radiology, nuclear medicine & medical imaging (18) 18
therapy (18) 18
calculating (17) 17
computing (17) 17
counting (17) 17
dose-response relationship, drug (17) 17
monoclonal-antibody (17) 17
psychiatry (17) 17
antibodies, monoclonal, humanized - administration & dosage (16) 16
pain (16) 16
rats, sprague-dawley (16) 16
rituximab (16) 16
agriculture (15) 15
antibodies, monoclonal, humanized (15) 15
low-back-pain (15) 15
magnetic resonance imaging (15) 15
nuclear experiment (15) 15
physics, particles & fields (15) 15
physiological aspects (15) 15
preparations for medical, dental, or toilet purposes (15) 15
recurrence (15) 15
antibodies, monoclonal - therapeutic use (14) 14
brain (14) 14
depression, mental (14) 14
ecology (14) 14
electric digital data processing (14) 14
management (14) 14
medicine (14) 14
nitric oxide (14) 14
particle physics (14) 14
quality of life (14) 14
radioimmunotherapy (14) 14
surveys and questionnaires (14) 14
child (13) 13
children (13) 13
epratuzumab (13) 13
forestry (13) 13
health aspects (13) 13
animal husbandry (12) 12
attitudes (12) 12
beer (12) 12
biochemistry (12) 12
cohort studies (12) 12
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (19) 19
UTL at Downsview - May be requested (5) 5
Royal Ontario Museum - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Stacks (2) 2
Online Resources - Online (2) 2
Aerospace - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (854) 854
German (43) 43
French (38) 38
Chinese (2) 2
Japanese (2) 2
Danish (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, ISBN 981428940X, 204
This is a book of testimonials from participants of the famous Erice International Seminars, which have addressed a long list of planetary problems and... 
Disasters | Emergency management
Book
Journal Article
Frontiers in Microbiology, ISSN 1664-302X, 2011, Volume 2, Issue JULY, p. 153
High throughput sequencing technology has opened a window into the vast communities of bacteria that live on and in humans, demonstrating tremendous... 
Intestinal protozoa | Host-associated communities | Eukaryotic diversity | host-associated communities | intestinal protozoa | MICROBIOLOGY | eukaryotic diversity | gut microbiome
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 19, pp. 2141 - 2148
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 07/2015, Volume 62, Issue 7, pp. 1171 - 1175
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 05/2018, Volume 70, Issue 5, pp. 763 - 773
Objective. EMBODY 1 (ClinicalTrials.gov identifier: NCT01262365) and EMBODY 2 (ClinicalTrials.gov identifier: NCT01261793) investigated the efficacy and safety... 
B-CELL RECEPTOR | PATHOGENESIS | CRITERIA | SAFETY | RITUXIMAB | DISEASE-ACTIVITY INDEX | BILAG-2004 INDEX | DOUBLE-BLIND | SUBSETS | CLASSIFICATION | RHEUMATOLOGY | Life Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 741 - 751
In an extension of a basket trial focusing on triple-negative breast cancer, patients who received sacituzumab govitecan, an antibody–drug conjugate, had a... 
CAPECITABINE | MEDICINE, GENERAL & INTERNAL | SN-38 | MONOTHERAPY | MANAGEMENT | THERAPY | CONJUGATE | OPEN-LABEL | PHASE-3 | TROP-2 | ACCELERATED APPROVAL | Irinotecan - administration & dosage | Humans | Middle Aged | Cell Adhesion Molecules - antagonists & inhibitors | Male | Antineoplastic Agents - therapeutic use | Diarrhea - chemically induced | Triple Negative Breast Neoplasms - drug therapy | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Aged, 80 and over | Immunoconjugates - therapeutic use | Adult | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Immunoconjugates - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm | Camptothecin - therapeutic use | Anemia - chemically induced | Survival Rate | Triple Negative Breast Neoplasms - mortality | Irinotecan - adverse effects | Progression-Free Survival | Aged | Infusions, Intravenous | Complications and side effects | Anemia | Dosage and administration | Breast cancer | Drug therapy | Risk factors | Antibody-drug conjugates | Data analysis | Nuclear magnetic resonance--NMR | Medical imaging | Body weight | Metastasis | FDA approval | Cancer therapies | Patients | Cell surface | Metastases | Chemotherapy | Medical prognosis | Response rates | Monoclonal antibodies | Solid tumors | Drug dosages | Neutropenia | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3843 - 3854
BACKGROUND Sacituzumab govitecan (IMMU‐132), an antitrophoblastic cell‐surface antigen (anti‐Trop‐2) humanized antibody‐SN‐38 conjugate, had encouraging... 
clinical trial | trophoblastic cell‐surface antigen (Trop‐2) | epithelial cancers | antibody‐drug conjugate | IMMU‐132 (sacituzumab govitecan) | SN‐38 | trophoblastic cell-surface antigen (Trop-2) | SN-38 | antibody-drug conjugate | IMMU-132 (sacituzumab govitecan) | METABOLITES | SOLID TUMORS | ETIRINOTECAN PEGOL NKTR-102 | CLINICAL PHARMACOKINETICS | BREAST-CANCER | EZN-2208 | ONCOLOGY | COLORECTAL-CANCER | THERAPEUTIC TARGET | IRINOTECAN | trophoblastic cellsurface antigen (Trop-2) | Neoplasms - metabolism | Humans | Middle Aged | Half-Life | Immunoconjugates - pharmacokinetics | Male | Response Evaluation Criteria in Solid Tumors | Immunoconjugates - administration & dosage | Glucuronosyltransferase - genetics | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Antibodies, Monoclonal, Humanized - pharmacokinetics | Camptothecin - blood | Aged, 80 and over | Antigens, Neoplasm - metabolism | Adult | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Immunoconjugates - adverse effects | Camptothecin - pharmacokinetics | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Cell Adhesion Molecules - metabolism | Neoplasms - drug therapy | Irinotecan | Aged | Immunoglobulin G - metabolism | Usage | Care and treatment | Safety and security measures | Analysis | Epithelial tumors | Pharmacokinetics | Antibody-drug conjugates | Camptothecin | Antigens | Toxicity | Immunoglobulin G | Radioactive half-life | Breast cancer | Pharmacology | Metastasis | Criteria | Patients | Cell surface | Metastases | Uridine | Safety | Solid tumors | Drug dosages | Cancer | Tumors | Half life | Neutropenia | Glucuronosyltransferase | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article